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Introduction
People who inject psychoactive drugs (such as heroin, cocaine and amphetamine) normally aim to inject intravenously, but often have difficulty with venous access either as a result of poor injection technique or because of the vascular damage that can occur over time when injecting regularly (Rhodes, Stoneman, Hope, Hunt, & Judd, 2006; Rhodes, Briggs, Kimber, Jones, & Holloway, 2007; Harris & Rhodes, 2012) . As a result they may have to make several injection attempts to gain venous access or use multiple areas of the body for injection (Darke, Ross, & Kaye, 2001; Maliphant & Scott, 2005; Harris & Rhodes, 2012) . This difficulty with vascular access can result in accidental subcutaneous and intramuscular injections -'missed hits' (Hankins , Palmer, & Singh, 2000; Rhodes, Briggs, Kimber, Jones, & Holloway, 2007) . In addition, for some people who inject psychoactive drugs (and also for those people who inject image and performance enhancing drugs, such as anabolic steroids and melanotan) their usual injection practice will be subcutaneous ('Skin Popping') or intramuscular ('Muscle Popping') (Binswanger, Kral, Bluthenthal, & Rybold, 2000; Pirozzi, Van, Pontious, & Meyr, 2014; .
Intentional or accidental subcutaneous and intramuscular injections among people who inject psychoactive drugs are known to be a risk factor for injection related bacterial infections (Binswanger, Kral, Bluthenthal, & Rybold, 2000; Pirozzi, Van, Pontious, & Meyr, 2014) , particularly those caused by anaerobic organisms, such as, wound botulism and tetanus (CDC, 1995; Brett, Hood, Brazier, Duerden, & Hahne, 2005; Palmateer, et al., 2013) .
Injections under the skin and into the muscle, particularly if they are accidental, could cause physical damage to tissues as a result of poor injection technique (Nicoll & Hesby, 2002; Ogston-Tuck, 2014) . In addition, the two most commonly injected psychoactive drugs in the United Kingdom, brown heroin and crack-cocaine, both need to be dissolved in acidic solutions (Scott, Winfield, Kennedy, & Bond, 2000; Scott & Ponton, 2004) . These acidic solutions when injected into vascular system are likely to be quickly diluted, but if injected under the skin or into the muscle (either during intentional subcutaneous and intramuscular injections or due to a 'missed hit') they could cause injecting site problems through chemical irritation and damage to these soft tissues (Lake & Beecroft , 2010) .
The extent of subcutaneous and intramuscular injections, including 'missed hits', and the factors associated with these have very rarely been studied. Several studies in the western USA, have reported on subcutaneous and intramuscular injections among people who inject drugs, though not on whether these injections were intentional or accidental. In a study from 1997 conducted in San Francisco, California, 22% reported subcutaneous or intramuscular injections in the previous 30 days (Binswanger, Kral, Bluthenthal, & Rybold, 2000) , and a more recent study from 2003-2005 indicated these practices were also common in Los Angeles, Oakland, and Berkeley, California, but didn't report on their extent (Fink, Lindsay, Slymen, Kral, & Bluthenth, 2013) . In a third study undertaken during 2010 in Seattle, Washington, 56% had ever injected intramuscularly (Coffin, Coffin, Murphy, Jenkins, & Golden, 2012) . However, the extent of these practices in the western USA may, in part at least, be related to the injection of 'black tar' heroin and the particular problems associated the use of this drug (Coffin, Coffin, Murphy, Jenkins, & Golden, 2012) , thus limiting the generalisability of these findings other areas with different patterns of drug use.
Considering the extent of injecting site infections among people who inject drugs in the United Kingdom (Hope, Kimber, Hickman, Vickerman, & Ncube, 2008) , in particular the substantial and ongoing problems with wound botulism and tetanus (Palmateer, et al., 2013; Anon, 2015) , data on the extent of, and the harms associated with, both intentional and accidental subcutaneous and intramuscular injections among this population are needed to help inform public health responses. Our study aimed to address this knowledge gap by asking participants about intentional subcutaneous or intramuscular injections and also about 'missed hits'. This paper describes:-a) the extent of subcutaneous injections, intramuscular injections, and 'missed hits'; b) the factors associated with reporting a 'missed hit'; and c) the extent of symptoms of injection site infections and injuries among those who report 'missed hits'.
Methods
People who inject drugs were recruited into a voluntary unlinked-anonymous cross-sectional survey in Bristol, a major urban area in the south west of England, United Kingdom, using respondent driven sampling (RDS) during the September and October of 2009. RDS is an established recruitment process which has been explained fully elsewhere (Salganik & Heckathorn, 2004; Heckathorn D. , 1997; Heckathorn D. , 2002) . Briefly, RDS starts with the selection of the initial recruits, or 'seeds', with further subjects then recruited through the participant's social networks. The 'seeds' (n=10) were selected in relation to location and gender through key informant referrals and street outreach. To be eligible, participants had to be aged over 15-years, have injected drugs during the preceding four weeks, live within the Bristol urban area (population: urban area 617,000; city 432,500) and give consent.
Participants provided a dried blood spot (DBS) sample (which was tested for antibodies to HIV [anti-HIV], the hepatitis B core antigen [anti-HBc], and the hepatitis C virus [anti-HCV]), underwent a computer-assisted interview, and were then offered an acknowledgement.
Participants were then asked to act as recruiters, and those who agreed to this were given three uniquely numbered and date-limited coupons. They were instructed to give these coupons only to eligible individuals whom they knew and received a further acknowledgement for each coupon that led to a successful participation. A single fieldwork co-ordinator screened all participants for eligibility and also for attempted repeat participations. The study had ethical approval (London REC, MREC/98/2/51).
The questionnaire used in the study was developed from ones that had previously been used with people who inject drugs in the United Kingdom (Judd, et al., 2005; Hickman, et al., 2007; Hickman, et al., 2009; . The questions on injection technique were developed from the existing questions about injecting practice. Participants were asked "How do you usually try to inject?" with answer options "In to a vein", "Under the Missed hits among in drug users. 6 skin -Skin Popping", or "In to the Muscle -Muscle Popping". Those injecting into vein were then asked if they had missed the vein when trying to inject and how often this occurred. The questionnaire was reviewed by members of the study team, including the fieldworkers, and by people working with people who inject drugs in the study area. The two main foci were: 1) injecting drug use (drugs used, paraphernalia used and injection practices); and 2) health harms (particularly infections) and uptake of health care related interventions. In addition, the questionnaire asked about demographics, environmental factors (such as contact with the criminal justice system and homelessness), and sexual behaviours.
In RDS studies there is a tendency for participants' to recruit people like themselves, and a higher probability that people with large networks will be recruited. For example, in our survey people who inject drugs who had been homeless in the last year had larger networks than those who had not, and recruited proportionally more people who were also homeless.
RDSTAT software (Version 5.4.0. Ithaca, New York: Volz E, Heckathorn DD; 2005) was used to test for evidence of selection bias and to generate sample derived weights; with age-group, homelessness and crack injection used to weight the data for analysis.
Weighted data were used in all of the analyses, which were undertaken using SPSS 19. First, bivariate associations between reporting a 'missed hit' and demographic characteristics, environmental factors, the drugs used, and injecting practices were examined using the χ 2 test. The environmental, drug use and injecting practice variables used in the analyses were for factors that had been shown in previous studies of either injecting risk practice or bacterial infections among people who inject drugs to be related to those outcomes (Hickman, et al., 2007; Hope, Kimber, Hickman, Vickerman, & Ncube, 2008; Salmon, Dwyer, Jauncey, van Beek, Topp, & Maher, 2009 ). Those characteristics found to be associated in the bivariate analyses were entered using the forward stepwise procedure in SPSS into a logistic regression model with inclusion assessed using the likelihood ratio (with the stepwise probability for inclusion of 0.05 and exclusion of 0.1).
Finally, considering that 'missed hits' may be a factor in the development of injecting site problems, the extent of symptoms of injection site infections or injuries among those who had aimed to inject intravenously were examined. Associations between these symptoms and reporting 'missed hits' were examined using the χ 2 test and logistic regression to adjust for possible confounding variables. In addition, associations were then examined using the χ 2 test between the frequency of reporting 'missed hits' and, a) symptoms of injection site infections and injuries, and b) seeking healthcare in response to these symptoms.
Results
Demographic and drug use characteristics.
Questionnaires were obtained from 329 individuals, weight characteristic a summarised in table 1. Briefly, their mean age was 33 years, one quarter were women, and half had been homeless during the preceding year. The mean time since they had first injected drugs was 12 years, almost all had injected heroin during the preceding three months and nearly threequarters had injected crack-cocaine. Two-thirds were receiving a detox or maintenance drug regime, such as opiate substitution therapy, and half reported that they had ever cleaned and then re-used needles and/or syringes.
Injection technique.
Overall, 99% (n=325) reported that the usually aimed to inject intravenously (table 1) , with only three participants reporting that they usually injected subcutaneously (i.e. under the skin or 'skin popping') and one reporting they usually injected intramuscularly (i.e. in to the muscle or 'muscle popping'). The four that did not usually aim to inject intravenously were all male, they were older (mean age of 44 years, median 43, vs. mean age of 33 years, median 33) and had been injecting for longer (mean time since first injection of 20 years, median 21, vs. mean time of 12 years, median 12).
Of those who usually aimed to inject intravenously, over half (56%, n=181) reported that they had ever missed a vein, that is accidentally injected subcutaneously or intramuscularly (a 'missed hit'). Of those who had ever missed a vein, 51% (n=92) reported that this happened less than once a month, for 21% (n=38) this typically happened between one and four times a month, and for 28% (n=51) 'missed hits' occurred more frequently. Reporting having had a 'missed hit' and the frequency of experiencing a 'missed hit' were both not associated with either age or gender.
Factors associated with 'missed hits' among those who aimed to inject intravenously.
The factors that were found to be associated in both the bivariate and multivariable analyses with 'missed hits' among the 325 participants who aimed to inject intravenously are shown in table 2. In the multivariate analysis, ever experiencing a 'missed hit' (table 2a) was more common among those who had been injecting for longer, those who had ever overdosed, those injected into their hands (though this was less common among those injecting into their groin), those who reported saving filters for reuse, and those who injected more frequently.
Experiencing a missed hit at least monthly (table 2b) was more common in the multivariate analysis among those who had inserted the needle three or more times on the last occasion that they had injected; those who had shared a needle or syringe; and those who had either reused spoons or saved filters. It also varied by the main area on body used for injecting and by the main source of needles and syringes.
Injection site infections and injuries among those aiming to inject intravenously
Overall of those who aimed to inject intravenously, 62% (n=201) reported ever having had redness, swelling & tenderness at an injection site, 44% (n=145) ever having had an abscess, and 14% (n=47) ever having had a sore or open wound. Ever reporting these three symptoms of an injection site infection and injury was around twice as common among those who reported that they had ever had 'missed hit' (table 3) .
Participants were also asked if they had any of these three symptoms during the preceding year; with 41% (n=133) reporting having had redness, swelling & tenderness at an injection site during the preceding year, 15% (n=48) an abscess, and 7.4% (n=24) a sore or open wound. The reporting of these symptoms during the preceding year became more common as the frequency of having 'missed hits' increased (table 4) , for example, among those reporting no 'missed hits' 4.9% reported that they had an abscess during the preceding year, this increased to 35% among those who reported having more than four 'missed hits' a month.
Those who reported having either an abscess or a sore/open wound at an injection site during the preceding year, were also asked if they had sought medical advice about either of these two symptoms from a doctor or a nurse (81%, 39/48, and 38%, 9/24, had respectively).
Reporting having had a 'missed hit', and the frequency of experiencing a 'missed hit' among those who had, were not associated with seeking medical advice from a doctor or a nurse about either of these two symptoms during preceding year.
Discussion
Our findings show that intentional subcutaneous or intramuscular injections are very rare among people who inject psychoactive drugs sampled, with these being reported by only around one in 100. However, such injections are actually a fairly common occurrence due to the 'missed hits' that occur when people fail to inject intravenously. Overall, more than half of those surveyed reported having had a 'missed hit', and for a quarter this happened at least once a month, with around one in six reporting having a 'missed hit' more than four times a month. Those who reported that they had experienced a 'missed hit' were twice as likely to also report having had symptoms of injection site infections and injuries.
First, it is important to consider the limitations of this study and also the generalizability of its findings. The comparative rarity of injecting drug use, its illegal nature, and the marginalisation of those involved are all barriers to the recruitment of a representative sample of people who inject drugs. This study aimed to minimize sampling biases and maximize representativeness by recruiting the participants through RDS (Heckathorn D. , 1997; Heckathorn D. , 2002; Salganik & Heckathorn, 2004) and applying sample derived weights to correct for possible recruitment biases; though it is not possible to test how successful this adjustment has been (Mills, Johnson, Hickman, Jones, & Colijn, 2014) . Even so, RDS is currently regarded as one of the most appropriate methods for recruiting community based samples of hidden populations, such as, people who inject drugs. Self-reports were used in this study, the accuracy of these can be questioned as they are potentially subject to recall bias, however, the reliability of self-reported risk behaviours among people who inject drugs has been previously shown (Latkin, Vlahov, & Anthony, 1993) . The cross-sectional approach used in this study allows the exploration of the factors associated with 'missed hits'; however, it does The extent of having ever injected subcutaneously or intramuscularly, either by intent or by accident, in our study was similar to the extent of ever injecting into the muscle found in Seattle, USA (Coffin, et al., 2012) , but higher than that reported in an study in San Francisco, California (Binswanger, Kral, Bluthenthal, & Rybold, 2000) . Subcutaneous and intramuscular injecting are likely to occur in other populations of people who inject drugs, particular among those populations were people have been injecting for long periods (Coffin, et al., 2012) . Over time these practices, and their associated harms, may become an issue among the ageing cohorts of people who inject drugs that are found in many high income countries (European Monitoring Centre for Drugs and Drug Addiction, 2010), where people who have been injecting for long periods will be come more common.
The finding that symptoms of injection site infections and injuries were associated with reporting a 'missed hit', and that these symptoms became more common as the frequency of having a 'missed hit' increased, corroborate information from case reports, studies of bacterial infections among people who inject drugs, and public health surveillance data that indicate that a wide range bacterial infections, including Meticillin-resistant Staphylococcus aureus and wound botulism, are more common among those who inject subcutaneously or intramuscularly (CDC, 1995; Binswanger, Kral, Bluthenthal, & Rybold, 2000; Lowy & Miller, 2002; Brett, Hood, Brazier, Duerden, & Hahne, 2005; Fink, Lindsay, Slymen, Kral, & Bluthenth, 2013; Pirozzi, Van, Pontious, & Meyr, 2014) . This probably reflects the damage to muscle and other soft tissues that can result from poor injection technique and/or injecting acidic solutions, making these injection sites particularly vulnerable to infections by organisms introduced during the injection process. When this damage leads to tissue necrosis it can result a local environment that is particularly suited to the growth of anaerobic organisms, such as the bacteria that cause botulism and tetanus (Brett, Hood, Brazier, Duerden, & Hahne, 2005; Palmateer, et al., 2013) .
Findings from studies that have looked at both injection site infections and injuries and injection practice suggest that a range of factors are associated with the occurrence of these problems, and many of these factors indicate that both poor injecting technique and hygiene probably play an important role in the development of these largely avoidable harms (Hope, Kimber, Hickman, Vickerman, & Ncube, 2008; Salmon, Dwyer, Jauncey, van Beek, Topp, & Maher, 2009; Hope, Cullen, Croxford, Parry, & Ncube, 2014) . They also indicate that the considerable harm caused by these infections and injuries, and the associated costs, can be amplified by delays in seeking healthcare (Marks, et al., 2013; .
A number of factors were found to be associated with reporting a 'missed hit'. Of particular note are the associations with having injected for longer, injecting into the hands, frequency of injection, and inserting the needle multiple times before injecting. These factors are probably a reflection of the vascular damage that can occur after injecting frequently over long periods of time, particularly if injection technique is poor (Harris & Rhodes, 2012) . This vascular damage makes accessing peripheral veins difficult, thus making missed hits more likely, but this can also result in people using potentially more dangerous injecting sites, such as, the hands, neck and groin (Darke, Ross, & Kaye, 2001) . There were also associations between reporting a 'missed hit' and aspects of injecting practicesuch as the sharing, reuse and saving of injecting equipment -that suggest that there may be a wider issue with poor injecting practice and hygiene amongst those experiencing 'missed hits'.
Public health interventions are needed to reduce the occurrence of 'missed hits' and the associated harms. These should look at ways to support and promote the use of good hygienic intravenous injection technique. The findings presented here, and those from previous studies undertaken in the United Kingdom (Maliphant & Scott, 2005; Hickman, et al., 2007; Harris & Rhodes, 2012; Hope, Cullen, Croxford, Parry, & Ncube, 2014) , indicate that there is considerable room to improve injection practice and hygiene through, for example, reducing the reuse of injecting equipment, more consistent cleaning of injections sites and the rotation of the body sites used for injection. Harm reduction responses should therefore include the development of interventions to support and promote good injection site management (including site rotation, always cleaning sites, always using new sterile equipment, and not using excessive acid), so as to minimize vein damage and thus reduce the vascular access problems that could lead to 'missed hits'. These should of course be supported by high coverage needle and syringe programmes, distributing a range of appropriate injecting equipment, including sterile needles, syringes and swabs (MacArthur, et al., 2014) .
Reporting 'missed hits' was less common among those who reported their 'groin' (femoral vein) as their main injection site. This possibly reflects that successfully injection into the femoral vein is easier due to the large size of this vein, which also allows the development of a sinus tract (Maliphant & Scott, 2005; Hope, J Scott, Cullen, Parry, Ncube, & Hickman, 2015) .
As a range of potentially serious harms have been associated with the injection into this particular body site, including deep vein thrombosis (McColl, Tait, Greer, & Walker, 2001; Hope, J Scott, Cullen, Parry, Ncube, & Hickman, 2015) , abscesses (Mackenzie, Laing, Douglas, Greaves, & Smith, 2000) , chronic venous disease (Pieper, Templin, Kirsner, & Birk, 2009 ), necrosis of the femoral artery (Mullan, Magowan, & Weir, 2008) , septicaemia (Hope, J Scott, Cullen, Parry, Ncube, & Hickman, 2015) and hepatitis C infection (Hope, J Scott, Cullen, Parry, Ncube, & Hickman, 2015) , its use should therefore not be promoted as a way of reducing the harms that could result from 'missed hits'. Instead priority should be given to improving injecting technique and vascular care, as well as to interventions to move people away injecting. Firstly, this should involve increasing the uptake of opiate substitution therapy (MacArthur, et al., 2014) , and secondly, if shown to be effective, supporting the use of alternative less risky routes of drug administration, such as through providing foil for the smoking drugs (Pizzey & Hunt, 2008 ; Advisory Council on the Misuse of Drugs, 2010).
Conclusions
This is the first study, to our knowledge, to purposively look at 'missed hits', subcutaneous and intramuscular injections among a community recruited sample of people who inject drugs.
Though only about one in 100 reported intentionally injecting subcutaneously or intramuscularly; 56% of the participants reported having had a 'missed hit', and for a quarter this happened at least once a month. The 'missed hits' here were associated with having injection site infections and injuries, and appeared to be associated with poor injection practice. Poor injection technique, and the difficulties with vascular access which can result from this, probably play a key role in the occurrence of 'missed hits', but this needs further Missed hits among in drug users. 14 investigation. Interventions to improve injecting technique and hygiene and to help sustain access to the peripheral veins are needed. All data presented in the table are weighted using sample derived weights.
